These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2445482)

  • 1. Phase II study of fludarabine phosphate in previously untreated patients with hepatoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Beltran G; Saiers JH; Oishi N; Von Hoff DD
    Cancer Treat Rep; 1987 Nov; 71(11):1111-2. PubMed ID: 2445482
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study.
    Harvey WH; Fleming TR; Von Hoff DD; Katterhagen JG; Coltman CA
    Cancer Treat Rep; 1987 Dec; 71(12):1319-20. PubMed ID: 2446754
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of fludarabine phosphate in patients with head and neck cancer: a Southwest Oncology Group Study.
    Weiss GB; Metch B; Von Hoff DD; Taylor SA; Saiers JH
    Cancer Treat Rep; 1987 Dec; 71(12):1313-4. PubMed ID: 2446753
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
    Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
    Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study.
    Weiss GR; Crowley J; Von Hoff DD; Taylor SA; Belt RJ; Coltman CA; Hynes HE; Costanzi JJ
    Cancer Treat Rep; 1986 Sep; 70(9):1123-4. PubMed ID: 2427196
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
    Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
    Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Carpenter JT; Vogel CL; Wang G; Raney M
    Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
    Von Hoff DD; Kronmal R; O'Toole RV; Surwit EA; Hutton JJ; Alberts DS
    Am J Clin Oncol; 1988 Apr; 11(2):146-8. PubMed ID: 2451882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
    Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
    J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
    Kraut EH; Crowley JJ; Grever MR; Keppen MD; Bonnet JD; Hynes HE; Salmon SE
    Invest New Drugs; 1990 May; 8(2):199-200. PubMed ID: 1696569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of fludarabine phosphate in small cell carcinoma. A Southwest Oncology Group Study.
    Rainey JM; Hill JB; Crowley J
    Invest New Drugs; 1988 Apr; 6(1):45-6. PubMed ID: 2457565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Brown TD; Fleming TR; Shildt RA; Cowan JD
    Cancer Treat Rep; 1987 Nov; 71(11):1101-2. PubMed ID: 2824048
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.
    Mittelman A; Savona S; Puccio C; Chun H; Ahmed T; Feldman E; Sullivan P; Arnold P; Arlin Z
    Invest New Drugs; 1990; 8 Suppl 1():S65-7. PubMed ID: 1696246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of fludarabine phosphate in patients with recurrent glioma.
    Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
    Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study.
    Shevrin DH; Lad TE; Kilton LJ; Cobleigh MA; Blough RR; Weidner LL; Vogelzang NJ
    Invest New Drugs; 1989 Jul; 7(2-3):251-3. PubMed ID: 2477345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas.
    Pazdur R; Samson MK; Baker LH
    Am J Clin Oncol; 1987 Aug; 10(4):341-3. PubMed ID: 2441592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of fludarabine (2-fluoro-ara-AMP).
    Kavanagh JJ; Krakoff IH; Bodey GP
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1009-11. PubMed ID: 2415365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of fludarabine phosphate in patients with advanced colorectal carcinoma.
    Ajani JA; Abbruzzese JL; Faintuch JS; Blackburn R; Levin B; Boman BM
    Invest New Drugs; 1988 Apr; 6(1):47-50. PubMed ID: 2457566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.